ZMe | organic nitrogen compounds d-out qh |
NT | +YCe enzymes qh ah | |
ZJ4.8.2e nitriles qh ah | ||
+ZN amines, imines, and imides qh ah | ||
+ZO amino acids, peptides, and proteins qh ah | ||
+ZPe alkaloids qh ah | ||
BT | +ZDe organic compounds qh ah |
ZM2e | nitrophenol qh |
HN | Introduced 1995. | |
BT | +ZF4e phenols qh ah |
ZM4e | verapamil qh |
BT | +YL6e antagonists qh ah | |
+YT8.14e calcium channel blockers qh ah |
ZM6e | urea qh |
RT | EB16.2 urea cycle qh ah | |
HF2e urinalysis qh ah | ||
XB2.10.4e urine qh ah |
ZM8e | phenformin qh |
RT | GR4.14e hypoglycemia qh ah |
ZN | amines, imines, and imides d-out qh |
BT | +ZMe organic nitrogen compounds qh ah |
ZN2e | . amines qh |
NT | +YH2.2 amine hormones qh ah | |
+YX4.2.2e nitrosamine qh ah | ||
ZK2.4.2.2.4.2e phosphatidylethanolamine qh ah | ||
ZT6.10.12.4e serotonin qh ah | ||
ZU6.2e mecamylamine qh ah | ||
RT | +YC14.6 amine oxidoreductases qh ah | |
+ZO amino acids, peptides, and proteins qh ah |
ZN2.4e | . . propylamine qh |
NT | ZT8.14.10e promethazine qh ah |
ZN2.4.2e | . . . fluoxetine qh |
BT | +YP4.8.2.2e serotonergic anti-alcohol-craving agents qh ah | |
+YP4.8.12.6 agents for alcohol-concurrent depression qh ah | ||
+YV6.6.2e serotonin uptake inhibitors qh ah |
ZN2.4.4e | . . . citalopram qh |
BT | +YP4.8.2.2e serotonergic anti-alcohol-craving agents qh ah | |
+YV6.6.2e serotonin uptake inhibitors qh ah |
ZN2.8e | . . catecholamines qh |
BT | +ZN2.18.2.2e biogenic monoamines qh ah |
ZN2.8.2e | . . . dobutamine qh |
ZN2.8.4e | . . . dopa qh |
ST | 3,4-dihydroxyphenylalanine | |
BT | +YV4.2 dopaminergic agents qh ah | |
+ZO2e amino acids qh ah | ||
+ZO2.2.2.12e phenylalanine qh ah | ||
RT | +YH2.2.6e epinephrine qh ah | |
+YH2.2.6.6e norepinephrine qh ah | ||
ZT6.10.10e melanin qh ah |
ZN2.8.4.2e | . . . . L-dopa qh |
ZN2.8.4.4e | . . . . cysteinyldopa qh |
ZN2.8.4.6e | . . . . levodopa qh |
ZN2.8.4.8e | . . . . methyldopa qh |
ZN2.8.4.8.2e | . . . . . carbidopa qh |
ZN2.8.6e | . . . dopamine qh |
NT | YH2.2.6.2 deoxyepinephrine qh ah | |
BT | +YJ2e neurotransmitters qh ah | |
+YJ2.4e monoamine neurotransmitters qh ah | ||
+YV4.2 dopaminergic agents qh ah | ||
+ZN2.18.2.2e biogenic monoamines qh ah | ||
RT | FP12.4e euphoria qh ah | |
XU4.8.4e adrenal medulla qh ah | ||
YK6.6e dopaminergic receptors qh ah | ||
+YL6e antagonists qh ah | ||
+ZP24.2e tetrahydroisoquinoline qh ah | ||
ZP24.2.2e salsolinol qh ah |
ZN2.8.6.2e | . . . . hydroxydopamine qh |
ZN2.10e | . . ethylamines qh |
ZN2.10.2e | . . . fenfluramine qh |
HN | Introduced 1995. | |
BT | +BT6.8.8 schedule IV appetite suppressants qh ah | |
+YT2e appetite suppressants qh ah | ||
+YV14e sympathomimetics qh ah |
ZN2.10.2.2e | . . . . norfenfluramine qh |
HN | Introduced 2000. |
ZN2.10.4e | . . . phenylethylamine qh |
NT | BF2.2 mescaline qh ah | |
+BJ2.2e amphetamines qh ah | ||
ZN2.16.2.14e ritodrine qh ah |
ZN2.10.6e | . . . phenoxybenzamine qh |
BT | +YT8.8 antihypertensive agents qh ah | |
+YV6.6e serotonin antagonists qh ah | ||
+YV12.2e alpha-adrenergic receptor blockaders qh ah |
ZN2.12e | . . fluvoxamine qh |
BT | +YP4.2e anti-alcohol-intoxication agents qh ah | |
+YP4.8.2.2e serotonergic anti-alcohol-craving agents qh ah | ||
+YP4.8.12.10 agents for alcohol-related cognitive impairment qh ah | ||
+YV6.6.2e serotonin uptake inhibitors qh ah |
ZN2.14e | . . hydroxylamine qh |
ZN2.14.2e | . . . oxime qh |
BT | +YD10.2 cholinesterase reactivators qh ah |
ZN2.14.2.2e | . . . . pralidoxime compound qh |
BT | +YD10.2 cholinesterase reactivators qh ah |
ZN2.16e | . . amino alcohols qh |
ST | alkylamine | |
BT | +ZF2e alcohols (chemical class) qh ah |
ZN2.16.2e | . . . ethanolamine qh |
ZN2.16.2.2e | . . . . albuterol qh |
ZN2.16.2.4e | . . . . phenylephrine qh |
BT | +YT8.4e vasoconstrictor agents qh ah | |
+YT8.10 cardiotonic agents qh ah | ||
+YV2 bronchodilator agents qh ah | ||
+YV14.2.2e alpha-adrenergic receptor agonists qh ah |
ZN2.16.2.6e | . . . . sotalol qh |
BT | +YV12.4e beta-adrenergic receptor blockaders qh ah |
ZN2.16.2.8e | . . . . terbutaline qh |
ZN2.16.2.10e | . . . . choline qh |
ZN2.16.2.10.2e | . . . . . succinylcholine qh |
BT | +YP4.8.10e conditioned alcohol aversion agents qh ah | |
+YT6.6 neuromuscular depolarizing agents qh ah | ||
+ZJ2.12.2.4e succinate qh ah |
ZN2.16.2.10.2.2e | . . . . . . succinylcholine chloride qh |
ST | Anectine | |
RT | +HK2.12.2e chemical aversion therapy qh ah |
ZN2.16.2.12e | . . . . isoproterenol qh |
ZN2.16.2.12.2e | . . . . . heptaminol qh |
ZN2.16.2.12.4e | . . . . . propanolamine qh |
ZN2.16.2.12.4.2e | . . . . . . propranolol qh |
HN | ETOH descriptor 1995. | |
BT | +YP4.6.6 beta blockers for alcohol withdrawal qh ah | |
+YP4.8.12.8 agents for alcohol-concurrent anxiety qh ah | ||
+YT8.2 antiarrhythmia agents qh ah | ||
+YT8.6e vasodilator agents qh ah | ||
+YT8.8 antihypertensive agents qh ah | ||
+YV12.4e beta-adrenergic receptor blockaders qh ah |
ZN2.16.2.12.4.4e | . . . . . . ephedrine qh |
HN | Introduced 2000. | |
SN | From the plant Ephedra equisetina. Chemically closely related to metamphetamine. | |
BT | +YW8e CNS stimulants qh ah |
ZN2.16.2.14e | . . . . ritodrine qh |
BT | +YV14.2.4e beta-adrenergic receptor agonists qh ah | |
+ZN2.10.4e phenylethylamine qh ah |
ZN2.16.2.16e | . . . . suloctidil qh |
BT | +YT8.6e vasodilator agents qh ah |
ZN2.16.2.18e | . . . . atenolol qh |
BT | +YP4.6.6 beta blockers for alcohol withdrawal qh ah |
ZN2.16.2.20e | . . . . methoxamine qh |
BT | +YT8.4e vasoconstrictor agents qh ah |
ZN2.16.2.22e | . . . . metoprolol qh |
ZN2.16.2.24e | . . . . nadolol qh |
ZN2.16.2.26e | . . . . timolol qh |
ZN2.18e | . . biogenic amines qh |
BT | +YJ2e neurotransmitters qh ah | |
RT | ZG2.10e biogenic aldehyde qh ah |
ZN2.18.2e | . . . acetylcholine qh |
BT | +YJ2e neurotransmitters qh ah | |
+YV4 neuroregulators qh ah | ||
RT | YC4.6.4.2.2e acetylcholinesterase qh ah |
ZN2.18.2.2e | . . . . biogenic monoamines qh |
NT | +YH2.2.6.6e norepinephrine qh ah | |
+ZN2.8e catecholamines qh ah | ||
+ZN2.8.6e dopamine qh ah | ||
+ZT6.10.12e tryptamine qh ah |
ZN2.18.2.2.2e | . . . . . histamine qh |
BT | +YJ2e neurotransmitters qh ah | |
+YM14 slow-reacting substances qh ah | ||
RT | +BX2.2.4e congener qh ah | |
+YKe receptors qh ah |
ZN2.18.2.2.2.2e | . . . . . . methylhistamine qh |
HN | Introduced 2000. |
ZN2.18.2.2.2.2.2e | . . . . . . . R alpha methylhistamine qh |
HN | Introduced 2000. | |
ST | MHA | |
BT | +YQ2e anti-inflammatory agents qh ah |
ZN2.18.2.2.4e | . . . . . tyramine qh |
BT | +YV14e sympathomimetics qh ah |
ZN2.18.2.2.4.2e | . . . . . . norsynephrine qh |
ZN2.18.2.2.4.4e | . . . . . . synephrine qh |
ZN2.18.2.4e | . . . . biogenic polyamines qh |
ZN2.18.2.4.2e | . . . . . cadaverine qh |
ZN2.18.2.4.4e | . . . . . putrescine qh |
ZN2.18.2.4.4.2e | . . . . . . spermidine qh |
ZN2.18.2.4.4.2.2e | . . . . . . . spermine qh |
ZN2.20e | . . amine derivatives qh |
NT | +ZO2e amino acids qh ah |
ZN2.20.2e | . . . amides qh |
BT | +ZJ4.8e nitrogen-containing carboxylic acid derivative qh ah |
ZN2.20.2.2e | . . . . acetamide qh |
RT | +ZJ2.6.4e acetic acid qh ah |
ZN2.20.2.2.2e | . . . . . piracetam qh |
HN | Introduced 1995. | |
BT | +ZT4.32.6e pyrrolidinone qh ah |
ZN2.20.2.2.4e | . . . . . thioacetamide qh |
BT | +YX4e carcinogens qh ah | |
+ZN2.20.8.8e thioamide qh ah |
ZN2.20.2.2.6e | . . . . . phenacetin qh |
BT | +YR2.2.6 gout suppressants qh ah |
ZN2.20.4e | . . . anilide qh |
ZN2.20.4.2e | . . . . acetanilide qh |
ZN2.20.4.4e | . . . . acetaminophen qh |
ST | paracetamol | |
Tylenol |
ZN2.20.4.4.2e | . . . . . lidocaine qh |
ZN2.20.6e | . . . benzamides qh |
BT | +ZJ2.10.10.2e benzoic acid qh ah |
ZN2.20.6.2e | . . . . hippurates qh |
BT | +ZJ2.10.6e keto acids qh ah |
ZN2.20.6.2.2e | . . . . . aminohippuric acid qh |
ZN2.20.6.2.2.2e | . . . . . . p-aminohippuric acid qh |
ZN2.20.6.4e | . . . . tiapride qh |
BT | +YP4.8.12.2 dopaminergic blockers for alcohol-concurrent mental disorders qh ah |
ZN2.20.6.6e | . . . . metoclopramide qh |
ZN2.20.6.8e | . . . . procarbazine qh |
BT | +YQ6 antineoplastic agents qh ah | |
+YX4e carcinogens qh ah |
ZN2.20.6.10e | . . . . sulpiride qh |
BT | +YW6e antidepressants qh ah |
ZN2.20.8e | . . . sulfonamide qh |
BT | +YQ4e anti-infective agents qh ah |
ZN2.20.8.2e | . . . . probenecid qh |
ZN2.20.8.4e | . . . . salicylazosulfapyridine qh |
ZN2.20.8.6e | . . . . sulfanilamide qh |
ZN2.20.8.6.2e | . . . . . furosemide qh |
ZN2.20.8.6.4e | . . . . . sulfadiazine qh |
ZN2.20.8.6.4.2e | . . . . . . silver sulfadiazine qh |
ZN2.20.8.6.6e | . . . . . sulfamethoxazole qh |
ZN2.20.8.6.8e | . . . . . sulfapyridine qh |
ZN2.20.8.6.10e | . . . . . sulfisoxazole qh |
ZN2.20.8.8e | . . . . thioamide qh |
NT | ZN2.20.2.2.4e thioacetamide qh ah |
ZN2.20.10e | . . . aniline compounds qh |
ZN2.20.14e | . . . phenylenediamine qh |
ZN2.22e | . . carbinolamine qh |
ZN4e | . imines qh |
ZN4.2e | . . polyethyleneimine qh |
ZN6e | . imides qh |
ZN6.2e | . . succinimide qh |
BT | +YW4.6e anticonvulsants qh ah | |
+ZJ2.12.2.4e succinate qh ah | ||
+ZT4.32.6e pyrrolidinone qh ah |
classification thesaurus glossary dictionary definition subject heading list ontology vocabulary knowledge structure knowledge organization terminology concept